106 related articles for article (PubMed ID: 4149885)
1. Interaction of anti-thymocyte serum with hematopoietic stem cells. I. Effects in vitro and in vivo.
Mookerjee BK; Azzolina L; Poultar L
J Immunol; 1974 Feb; 112(2):822-9. PubMed ID: 4149885
[No Abstract] [Full Text] [Related]
2. Interaction of anti-thymocyte serum with haematopoietic stem cells. II. Stimulation of colony formation in vitro.
Mookerjee BK; Poulter L
Immunology; 1974 Oct; 27(4):601-7. PubMed ID: 4140146
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the graft-versus-host reaction. I. Reduction of the graft-versus-host potential of mouse spleen cells (with a sparing of stem cells) by treatment with antilymphocyte globulin-derived Fab fragments.
Gallagher MT; Richie ER; Heim LR; Judd KP; Trentin JJ
Transplantation; 1972 Nov; 14(5):597-602. PubMed ID: 4404282
[No Abstract] [Full Text] [Related]
4. Anti-lymphocytic antibodies and marrow transplantation. 3. Effect of heterologous anti-brain antibodies on acute secondary disease in mice.
Rodt H; Thierfelder S; Eulitz M
Eur J Immunol; 1974 Jan; 4(1):15-9. PubMed ID: 4152781
[No Abstract] [Full Text] [Related]
5. An in vitro reaction between lymphoid cells and target fibroblastic cells: a possible model for in vivo rejection of haemopoietic allografts.
Mayhew E; Bennett M
Immunology; 1971 Jul; 21(1):123-36. PubMed ID: 4934136
[TBL] [Abstract][Full Text] [Related]
6. Synergism between lymph node and bone marrow cells for production of granulocytes. I. Requirement for immunocompetent cells.
Kanamaru A; Kitamura Y; Kawata T; Okano K
Exp Hematol; 1974; 2(1):35-42. PubMed ID: 4155687
[No Abstract] [Full Text] [Related]
7. [Antilymphocyte serum: production, basic properties and clinical use (review of the literature)].
Shabalin VN
Vestn Khir Im I I Grek; 1972 Aug; 109(8):131-6. PubMed ID: 4126160
[No Abstract] [Full Text] [Related]
8. Characterization of the anti-stem cell activity of anti-mouse brain serum.
Monette FC; Eichacker PQ; Garver RI; Byrt W; Gilio MJ
Exp Hematol; 1978 Mar; 6(3):299-310. PubMed ID: 648593
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of haemopoietic stem cells by syngeneic lymphocytes treated with antilymphocyte serum.
Kaulen DR; Golovanova TA; Pyatikhina DP; Khorobrikh VV
Folia Biol (Praha); 1975; 21(2):95-102. PubMed ID: 1100442
[TBL] [Abstract][Full Text] [Related]
10. Hemopoietic inductive envirnment necessary for an early stage in differentiation of thymic immune cells: effect of antilymphocytic serum.
Bennett M
J Cell Physiol; 1972 Apr; 79(2):309-16. PubMed ID: 4402104
[No Abstract] [Full Text] [Related]
11. Thymus: an essential factor in lymphoid repopulation.
Stutman O; Yunis EJ; Good RA
Transplant Proc; 1969 Mar; 1(1):614-5. PubMed ID: 4400068
[No Abstract] [Full Text] [Related]
12. Effect of ALS on transplanted lymph node cells: determination of time required for inactivation of CFU by allogeneic lymphocytes.
Manyko VM; Petrov RV; Sidorovich IG; Kraskina NA
Folia Biol (Praha); 1973 Sep; 19(5):305-14. PubMed ID: 4772340
[No Abstract] [Full Text] [Related]
13. Effects of natural thymocytotoxic autoantibody of NZB mice and of specifically prepared antilymphocyte serum on the tissue distribution of 51 Cr-labeled lymphocytes.
Shirai T; Yoshiki T; Mellors RC
J Immunol; 1973 Feb; 110(2):517-23. PubMed ID: 4539675
[No Abstract] [Full Text] [Related]
14. Prevention of acute graft-versus-host (GVH) mortality with spleen-absorbed antithymocyte globulin (ATG).
Trentin JJ; Judd KP
Transplant Proc; 1973 Mar; 5(1):865-8. PubMed ID: 4540468
[No Abstract] [Full Text] [Related]
15. In vivo activity of cytotoxic lymphocytes.
Cerottini JC; Freedman LR; Brunner KT
Transplant Proc; 1972 Sep; 4(3):299-301. PubMed ID: 4404149
[No Abstract] [Full Text] [Related]
16. Thymocyte involvement in spleen colony formation by subpopulations of hematopoietic stem cells.
Monette FC; Wassef WY
Exp Hematol; 1981 Nov; 9(10):1011-9. PubMed ID: 6975721
[TBL] [Abstract][Full Text] [Related]
17. Antilymphocytic antibodies and marrow transplantation. IV. Comparison of the effects of antibody fragments directed against immunoglobulin or lymphocyte antigens on acute secondary disease.
Rodt H; Therfelder S; Eulitz M
Exp Hematol; 1974; 2(4):195-203. PubMed ID: 4156327
[No Abstract] [Full Text] [Related]
18. Dichotomy and improved specificity of immunosuppressive effect of anti-thymocyte globulin.
Judd KP; Bryant CJ; Trentin JJ
J Immunol; 1972 May; 108(5):1461-4. PubMed ID: 4555122
[No Abstract] [Full Text] [Related]
19. Mouse bone marrow lymphocytes and their differentiation.
Ryser JE; Vassalli P
J Immunol; 1974 Sep; 113(3):719-28. PubMed ID: 4213258
[No Abstract] [Full Text] [Related]
20. Expression of antigens of the 'T200' family of glycoproteins on hemopoietic stem cells: evidence that thymocyte cell lineage antigens are represented on 'T200'.
Ralph SJ; Berridge MV
J Immunol; 1984 May; 132(5):2510-4. PubMed ID: 6425407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
